{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:00:52Z","timestamp":1789999252990,"version":"4.0.1"},"reference-count":95,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer remains one of the deadliest gynecologic malignancies because of late-stage diagnosis, biological heterogeneity, and the lack of effective early detection strategies. Epithelial ovarian cancer (EOC) comprises several histotypes, including high-grade serous carcinoma (HGSC), low-grade serous carcinoma (LGSC), endometrioid ovarian carcinoma (ENOC), clear cell ovarian carcinoma (CCOC), and mucinous ovarian carcinoma (MOC), each with distinct molecular pathways and precursor lesions. In recent years, serous tubal intraepithelial carcinoma (STIC) has emerged as the principal precursor lesion of HGSC, supporting the fallopian tube origin paradigm of ovarian carcinogenesis. This structured scoping review summarizes current evidence on the molecular and cellular origins of epithelial ovarian cancer, with particular emphasis on precursor lesions, including p53 signatures, SCOUTs, STILs, cortical inclusion cysts, endometriosis-associated lesions, and borderline ovarian tumors. Particular attention is given to the molecular events that drive progression toward invasive carcinoma, including TP53 mutations, BRCA1\/2 dysfunction, homologous recombination deficiency, chromosomal instability, telomere shortening, cell-cycle dysregulation, stemness-associated pathways, and inflammatory signaling. A structured literature search was conducted in PubMed\/MEDLINE, Scopus, and Web of Science to identify studies published from 2000 to 2026 that addressed ovarian cancer precursor lesions, molecular pathogenesis, and early carcinogenic mechanisms. Articles were selected for relevance to epithelial ovarian carcinogenesis, precursor biology, and translational implications. Current evidence supports substantial biological heterogeneity among precursor lesions, particularly STICs, with only a subset likely to progress to invasive HGSC. Emerging molecular approaches, including genome-wide aneuploidy profiling and integrated genomic classifiers, may improve risk stratification and facilitate earlier detection of clinically significant precursor lesions. A better understanding of precursor biology may ultimately contribute to personalized prevention strategies and improved clinical outcomes in ovarian cancer.<\/jats:p>","DOI":"10.3390\/cancers18183036","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:03Z","timestamp":1789995003000},"page":"3036","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ovarian Precancerous Lesions and Their Molecular Landscape: A Structured Scoping Review Focused on STIC and Related Precursors of Epithelial Ovarian Cancer"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2055-5914","authenticated-orcid":false,"given":"Katarzyna","family":"Kwas-Sarnacka","sequence":"first","affiliation":[{"name":"Department of Surgical and Oncologic Gynecology, 1st Department of Gynecology and Obstetrics, Medical University of Lodz, ul. Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"Lisi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Surgical and Oncologic Gynecology, 1st Department of Gynecology and Obstetrics, Medical University of Lodz, ul. Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-1223","authenticated-orcid":false,"given":"Edward","family":"Kozir\u00f3g","sequence":"additional","affiliation":[{"name":"Department of Surgical and Oncologic Gynecology, 1st Department of Gynecology and Obstetrics, Medical University of Lodz, ul. Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2721-473X","authenticated-orcid":false,"given":"Kinga","family":"Stanek","sequence":"additional","affiliation":[{"name":"Department of Surgical and Oncologic Gynecology, 1st Department of Gynecology and Obstetrics, Medical University of Lodz, ul. Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-8725","authenticated-orcid":false,"given":"Daniel","family":"Wolder","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Jan Kochanowski University of Kielce, 25-369 Kielce, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-0076","authenticated-orcid":false,"given":"Maria","family":"Szubert","sequence":"additional","affiliation":[{"name":"Department of Surgical and Oncologic Gynecology, 1st Department of Gynecology and Obstetrics, Medical University of Lodz, ul. Pomorska 251, 92-213 Lodz, Poland"},{"name":"Borahay\u2019s Lab, Department of Gynecology and Obstetrics, Johs Hopkins Research Institute, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2072-6533","authenticated-orcid":false,"given":"Jacek","family":"Wilczy\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Surgical and Oncologic Gynecology, 1st Department of Gynecology and Obstetrics, Medical University of Lodz, ul. Pomorska 251, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref_1","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: A review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Papp","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-Associated Mutations in Endometriosis without Cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma","volume":"95","author":"Singer","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","first-page":"292","article-title":"Incessant ovulation and ovarian cancer\u2014A hypothesis re-visited","volume":"5","author":"Fathalla","year":"2013","journal-title":"Facts Views Vis. Obgyn"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2013.12.015","article-title":"Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma","volume":"132","author":"Brand","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: A new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/1078-0432.CCR-21-1643","article-title":"The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma","volume":"28","author":"Cheng","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: Pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Koshiyama, M., Matsumura, N., and Konishi, I. (2017). Subtypes of Ovarian Cancer and Ovarian Cancer Screening. Diagnostics, 7.","DOI":"10.3390\/diagnostics7010012"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: A descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/onc.2016.455","article-title":"PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer","volume":"36","author":"Modi","year":"2017","journal-title":"Oncogene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PGP.0000000000000123","article-title":"Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: A pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer)","volume":"34","author":"Seidman","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/modpathol.2017.53","article-title":"LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions","volume":"30","author":"Schmoeckel","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/0008-5472.CAN-25-3189","article-title":"Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions","volume":"86","author":"Chang","year":"2026","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/PAS.0b013e3181868904","article-title":"Serous tubal intraepithelial carcinoma and the dominant ovarian mass: Clues to serous tumor origin?","volume":"33","author":"Roh","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Luvero, D., Angioli, R., Notaro, E., Plotti, F., Terranova, C., Angioli, A.M., Festa, A., Stermasi, A., Manco, S., and Diserio, M. (2024). Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery. Diagnostics, 14.","DOI":"10.3390\/diagnostics14222577"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-18-0009","article-title":"Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study","volume":"11","author":"Visvanathan","year":"2018","journal-title":"Cancer Prev. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited Mutations in Women with Ovarian Carcinoma","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Otsuka, I. (2021). Mechanisms of High-Grade Serous Carcinogenesis in the Fallopian Tube and Ovary: Current Hypotheses, Etiologic Factors, and Molecular Alterations. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094409"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"932371","DOI":"10.1155\/2010\/932371","article-title":"Ovarian cancer pathogenesis: A model in evolution","volume":"2010","author":"Karst","year":"2010","journal-title":"J. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"100890","DOI":"10.1016\/j.modpat.2025.100890","article-title":"A Subset of Serous Tubal Intraepithelial Carcinoma (STIC)-Like Lesions and Concurrent High-Grade Endometrial Carcinoma Are Genomically Related Entities","volume":"38","author":"Paula","year":"2025","journal-title":"Mod. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5219","article-title":"Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions","volume":"248","author":"Wu","year":"2019","journal-title":"J. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Saleh, A., and Perets, R. (2021). Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy. Cancers, 13.","DOI":"10.3390\/cancers13143465"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/joim.20106","article-title":"The TP53 tumor suppressor gene: From molecular biology to clinical investigations","volume":"298","author":"Baliakas","year":"2025","journal-title":"J. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/PAS.0000000000002187","article-title":"Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions","volume":"48","author":"Chien","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/2159-8290.CD-24-1366","article-title":"Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma","volume":"15","author":"Kader","year":"2025","journal-title":"Cancer Discov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.18632\/oncotarget.23747","article-title":"Expression and function of nuclear receptor coactivator 4 isoforms in transformed endometriotic and malignant ovarian cells","volume":"9","author":"Rockfield","year":"2017","journal-title":"Oncotarget"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/path.6322","article-title":"The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions","volume":"264","author":"Cheng","year":"2024","journal-title":"J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101359","DOI":"10.1016\/j.gore.2024.101359","article-title":"Clinical outcomes following identification of an incidental p53 signature in the fallopian tube","volume":"52","author":"MacARTHUR","year":"2024","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The Origin of Ovarian Cancer Species and Precancerous Landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Hsu, C.F., Chen, P.C., Seenan, V., Ding, D.C., and Chu, T.Y. (2021). Ovulatory Follicular Fluid Facilitates the Full Transformation Process for the Development of High-Grade Serous Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13030468"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.3802\/jgo.2022.33.e50","article-title":"TP53 variants in p53 signatures and the clonality of STICs in RRSO samples","volume":"33","author":"Akahane","year":"2022","journal-title":"J. Gynecol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"a026187","DOI":"10.1101\/cshperspect.a026187","article-title":"Inherited TP53 Mutations and the Li-Fraumeni Syndrome","volume":"7","author":"Guha","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-030-22254-3_15","article-title":"Tumor Dormancy and Slow-Cycling Cancer Cells","volume":"1164","author":"Davis","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1593\/neo.11138","article-title":"Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma","volume":"13","author":"Jazaeri","year":"2011","journal-title":"Neoplasia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53; Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Dai, Y., Xu, J., Gong, X., Wei, J., Gao, Y., Chai, R., Lu, C., Zhao, B., and Kang, Y. (2024). Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020886"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1158\/0008-5472.CAN-20-1830","article-title":"BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis","volume":"80","author":"Krais","year":"2020","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1038\/s41598-022-08461-0","article-title":"BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling","volume":"12","author":"Bradbury","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Arakelyan, A., Melkonyan, A., Hakobyan, S., Boyarskih, U., Simonyan, A., Nersisyan, L., Nikoghosyan, M., Filipenko, M., and Binder, H. (2021). Transcriptome Patterns of BRCA1- and BRCA2- Mutated Breast and Ovarian Cancers. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031266"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1038\/s41467-025-58145-2","article-title":"Impact of BRCA mutations, age, surgical indication, and hormone status on the molecular phenotype of the human Fallopian tube","volume":"16","author":"Beddows","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Pavanello, M., Vieira, C.M., Arenhardt, M.P., and Nogueira-Rodrigues, A. (2025). Homologous Recombination Proficiency in High-Grade Serous Epithelial Ovarian Cancer Tumors: The Dark Side of the Moon. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47090702"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Delaney, J.R., Patel, C.B., Bapat, J., Jones, C.M., Ramos-Zapatero, M., Ortell, K.K., Tanios, R., Haghighiabyaneh, M., Axelrod, J., and DeStefano, J.W. (2020). Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors. PLoS Genet., 16.","DOI":"10.1371\/journal.pgen.1008558"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.3390\/cimb46090555","article-title":"Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor","volume":"46","author":"Kanno","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"031902","DOI":"10.1063\/1.5022595","article-title":"The Extracellular Matrix of Ovarian Cortical Inclusion Cysts Modulates Invasion of Fallopian Tube Epithelial Cells","volume":"2","author":"Fleszar","year":"2018","journal-title":"APL Bioeng."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PGP.0000000000000120","article-title":"Two types of ovarian cortical inclusion cysts: Proposed origin and possible role in ovarian serous carcinogenesis","volume":"34","author":"Banet","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/his.13444","article-title":"Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy","volume":"72","author":"Park","year":"2018","journal-title":"Histopathology"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Pothuri, B., Leitao, M.M., Levine, D.A., Viale, A., Olshen, A.B., Arroyo, C., Bogomolniy, F., Olvera, N., Lin, O., and Soslow, R.A. (2010). Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010358"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8659754","DOI":"10.1155\/2019\/8659754","article-title":"Tubal Origin of \u201cOvarian\u201d Low-Grade Serous Carcinoma: A Gene Expression Profile Study","volume":"2019","author":"Wang","year":"2019","journal-title":"J. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Murakami, K., Kotani, Y., Nakai, H., and Matsumura, N. (2020). Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy. Cancers, 12.","DOI":"10.3390\/cancers12061676"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1078-0432.CCR-07-1614","article-title":"Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress","volume":"14","author":"Yamaguchi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10147-009-0931-2","article-title":"Ovarian cancer in endometriosis: Epidemiology, natural history, and clinical diagnosis","volume":"14","author":"Kobayashi","year":"2009","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_73","first-page":"e66128","article-title":"Endometriosis: A Comprehensive Exploration of Inflammatory Mechanisms and Fertility Implications","volume":"16","author":"Rathod","year":"2024","journal-title":"Cureus"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.fertnstert.2025.07.386","article-title":"Association between endometriosis and m\u00fcllerian anomalies: A retrospective study supporting the retrograde menstruation theory","volume":"124","author":"Zhang","year":"2025","journal-title":"Fertil. Steril."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ioannidou, A., Sakellariou, M., Sarli, V., Panagopoulos, P., and Machairiotis, N. (2025). New Evidence About Malignant Transformation of Endometriosis-A Systematic Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14092975"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20240976","DOI":"10.1515\/med-2024-0976","article-title":"Molecular landscape of borderline ovarian tumours: A systematic review","volume":"19","author":"Sadlecki","year":"2024","journal-title":"Open Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2353\/ajpath.2010.100212","article-title":"BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas","volume":"177","author":"Wong","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.2147\/CMAR.S250394","article-title":"The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives","volume":"12","author":"Sun","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13053-022-00218-0","article-title":"Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor","volume":"20","author":"Ogrodniczak","year":"2022","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent","volume":"30","author":"Silva","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2010.01.006","article-title":"Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary","volume":"117","author":"May","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000336140","article-title":"Borderline tumors of the ovary: Clinical course and prognostic factors","volume":"35","author":"Kommoss","year":"2012","journal-title":"Onkologie"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ygyno.2005.02.022","article-title":"Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer","volume":"97","author":"Gotlieb","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"ref_84","unstructured":"Basta, A., Bidzi\u0144ski, M., Bie\u0144kiewicz, A., Blecharz, P., Bodnar, L., Jach, R., Knapp, P., Kojs, Z., Kotarski, J., and Markowska, J. (2025). Recommendations of the Polish Society of Gynecologic Oncology for the Diagnosis and Treatment of Ovarian Cancer, Via Medica."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/sj.bjc.6602199","article-title":"BRCA1 mutations in ovarian cancer and borderline tumours in Norway: A nested case-control study","volume":"91","author":"Lie","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Lhotova, K., Stolarova, L., Zemankova, P., Vocka, M., Janatova, M., Borecka, M., Cerna, M., Jelinkova, S., Kral, J., and Volkova, Z. (2020). Multigene panel germline testing of 1333 Czech patients with ovarian cancer. Cancers, 12.","DOI":"10.3390\/cancers12040956"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Davidson, B., Trope, C.G., and Reich, R. (2014). The role of the tumor stroma in ovarian cancer. Front. Oncol., 4.","DOI":"10.3389\/fonc.2014.00104"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","article-title":"Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review","volume":"158","author":"Kahn","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamasurg.2023.4770","article-title":"Prophylactic Salpingo-Oophorectomy and Survival After BRCA1\/2 Breast Cancer Resection","volume":"158","author":"Martelli","year":"2023","journal-title":"JAMA Surg."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.6004\/jnccn.2026.0007","article-title":"NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026","volume":"24","author":"Cheng","year":"2026","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cncr.32620","article-title":"Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries","volume":"126","author":"Crafton","year":"2020","journal-title":"Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13224-018-1155-z","article-title":"Evaluation of SEE-FIM (Sectioning and Extensively Examining the FIMbriated End) Protocol in Identifying Fallopian Tube Precursor Lesions in Women with Ovarian Tumors","volume":"69","author":"Arora","year":"2019","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Canlorbe, G., Chabbert-Buffet, N., and Uzan, C. (2021). Fertility-Sparing Surgery for Ovarian Cancer. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184235"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e7132","DOI":"10.1002\/cam4.7132","article-title":"Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study","volume":"13","author":"Lee","year":"2024","journal-title":"Cancer Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:09:48Z","timestamp":1789996188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/3036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":95,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18183036"],"URL":"https:\/\/doi.org\/10.3390\/cancers18183036","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}